Integral Diagnostics Ltd (ASX: IDX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Integral Diagnostics Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $850.59 million
P/E Ratio 39.83
Dividend Yield 4.03%
Shares Outstanding 373.07 million
Earnings per share 0.058
Dividend per share 0.09
Year To Date Return -5.39%
Earnings Yield 2.51%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Integral Diagnostics Ltd (ASX: IDX)
    Latest News

    A man sees some good news on his phone and gives a little cheer.
    Share Gainers

    Why Capitol Health, Infratil, Newmont, and Race Oncology shares are charging higher

    These shares are having a good session. But why?

    Read more »

    Red buy button on an Apple keyboard with a finger on it.
    Broker Notes

    Buy 'em now! Brokers name 3 ASX All Ords shares to add to your portfolio

    Copper, technology, and healthcare are the themes among these newly buy-rated stocks.

    Read more »

    A young man clasps his hand to his head with a pained expression on his face and a laptop in front of him.
    Share Fallers

    Why Bapcor, Chalice Mining, Integral Diagnostics, and Winsome Resources shares are dropping

    These shares are having a tough session on Monday. But why?

    Read more »

    Two happy and excited friends in euphoria holding a smartphone, after winning in a bet.
    Share Gainers

    Why Capitol Health, Capricorn Metals, Credit Clear, and Telix shares are storming higher

    These shares are starting the week with a bang. But why?

    Read more »

    Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital
    Healthcare Shares

    This ASX All Ords stock is rocketing 20% after accepting a takeover offer

    These two diagnostics companies are planning to merge their operations.

    Read more »

    In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
    Healthcare Shares

    2 ASX healthcare shares to buy now for the AI revolution

    Experts expect mouth-watering growth from AI for these healthcare companies.

    Read more »

    Woman going for a scan reassured by doctor
    Healthcare Shares

    How AI could boost this ASX 300 healthcare stock

    The Firetrail investment management team see AI providing a 'material tailwind' for this stock.

    Read more »

    Shot of two young scientists using a laptop in a laboratory.
    Healthcare Shares

    2 ASX healthcare shares with 'compelling' valuations to buy

    The QVE team reckons this pair of small caps can be bought for cheap right now, but could rocket very…

    Read more »

    Smiling couple looking at a phone at a bargain opportunity.
    Cheap Shares

    'Compelling growth prospects': 2 ASX shares to buy while they're cheap

    Sure it's scary to see a stock do a freefall. But the best investors take advantage of those violent dips.

    Read more »

    A worried man holds his head and look at his computer.
    Share Fallers

    Why Aussie Broadband, Bowen Coal, Integral Diagnostics, and Treasury Wine are falling today

    These ASX shares are ending the week in the red. But why?

    Read more »

    A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
    Healthcare Shares

    Guess which ASX All Ords share is crashing 30% today

    Investors have been hitting the sell button in a panic on Friday.

    Read more »

    A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
    Share Fallers

    Why Atlantic Lithium, Integral Diagnostics, Nexted, and Serko shares are falling today

    These ASX shares are missing out on the good times on Tuesday.

    Read more »

    Frequently Asked Questions

    Yes, Integral Diagnostics historically pays two fully franked dividends a year.

    Integral Diagnostics generally pays its shareholder dividends in April and October.

    Integral Diagnostics Ltd listed on the ASX on 21 October 2015.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    28 Aug 2026 $0.0600 100.00% Final 02 Oct 2026
    04 Mar 2026 $0.0330 100.00% Interim 02 Apr 2026
    29 Aug 2025 $0.0400 100.00% Final 03 Oct 2025
    06 Mar 2025 $0.0250 100.00% Interim 07 Apr 2025
    30 Aug 2024 $0.0330 100.00% Final 03 Oct 2024
    29 Feb 2024 $0.0250 100.00% Interim 02 Apr 2024
    31 Aug 2023 $0.0350 100.00% Final 04 Oct 2023
    02 Mar 2023 $0.0250 100.00% Interim 04 Apr 2023
    01 Sep 2022 $0.0300 100.00% Final 05 Oct 2022
    01 Mar 2022 $0.0400 100.00% Interim 04 Apr 2022
    02 Sep 2021 $0.0700 100.00% Final 06 Oct 2021
    01 Mar 2021 $0.0550 100.00% Interim 06 Apr 2021
    28 Aug 2020 $0.0400 100.00% Final 01 Oct 2020
    28 Feb 2020 $0.0550 100.00% Interim 07 Apr 2020
    30 Aug 2019 $0.0500 100.00% Final 02 Oct 2019
    01 Mar 2019 $0.0500 100.00% Interim 02 Apr 2019
    31 Aug 2018 $0.0400 100.00% Final 04 Oct 2018
    31 Jan 2018 $0.0400 100.00% Interim 05 Mar 2018
    31 Aug 2017 $0.0000 100.00% Final 04 Oct 2017
    28 Feb 2017 $0.0300 100.00% Interim 30 Mar 2017
    31 Aug 2016 $0.0400 100.00% Final 04 Oct 2016

    IDX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Integral Diagnostics Ltd

    Integral Diagnostics Ltd (ASX: IDX) is an Australian healthcare services company providing medical imaging services. The group operates in a single business providing diagnostic imaging to general practitioners, medical specialists, and allied health professionals and their patients.

    Following its transformational merger with Capitol Health, completed in December 2024, the combined group operates more than 155 radiology clinics across Australia and New Zealand, supported by over 350 radiologists. IDX is also a joint venture partner in Medx, expanding its services to the United Kingdom and Ireland.

    IDX Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    10 Sep 2026 $2.29 $-0.02 -0.87% 761,559 $2.30 $2.31 $2.27
    09 Sep 2026 $2.31 $-0.04 -1.70% 528,597 $2.28 $2.33 $2.28
    08 Sep 2026 $2.35 $0.02 0.86% 515,418 $2.34 $2.35 $2.32
    07 Sep 2026 $2.33 $0.02 0.87% 591,314 $2.32 $2.35 $2.30
    04 Sep 2026 $2.31 $0.03 1.32% 1,498,450 $2.28 $2.31 $2.27
    03 Sep 2026 $2.28 $-0.07 -2.98% 1,282,998 $2.35 $2.35 $2.27
    02 Sep 2026 $2.35 $0.01 0.43% 1,452,161 $2.34 $2.40 $2.32
    01 Sep 2026 $2.34 $0.05 2.18% 1,561,857 $2.30 $2.35 $2.26
    31 Aug 2026 $2.29 $0.04 1.78% 728,758 $2.25 $2.31 $2.25
    28 Aug 2026 $2.25 $-0.08 -3.43% 885,013 $2.27 $2.31 $2.25
    27 Aug 2026 $2.33 $0.00 0.00% 2,039,066 $2.33 $2.33 $2.30
    26 Aug 2026 $2.33 $-0.07 -2.92% 1,276,094 $2.42 $2.43 $2.32
    25 Aug 2026 $2.40 $0.12 5.26% 2,484,873 $2.30 $2.46 $2.19
    24 Aug 2026 $2.28 $0.03 1.33% 751,305 $2.27 $2.30 $2.25
    21 Aug 2026 $2.25 $-0.03 -1.32% 862,260 $2.28 $2.28 $2.21
    20 Aug 2026 $2.28 $0.04 1.79% 1,163,405 $2.25 $2.28 $2.20
    19 Aug 2026 $2.24 $-0.02 -0.88% 1,153,356 $2.26 $2.28 $2.23
    18 Aug 2026 $2.26 $0.03 1.35% 1,160,964 $2.28 $2.28 $2.22
    17 Aug 2026 $2.23 $-0.01 -0.45% 573,250 $2.26 $2.26 $2.22
    14 Aug 2026 $2.24 $0.01 0.45% 994,361 $2.25 $2.26 $2.21
    13 Aug 2026 $2.23 $0.01 0.45% 1,631,548 $2.25 $2.27 $2.22
    12 Aug 2026 $2.22 $0.00 0.00% 1,938,700 $2.15 $2.24 $2.15

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    28 Aug 2026 Jason Martinez Buy 30,000 $71,700
    On-market trade.
    28 Aug 2026 Ingrid Player Buy 10,000 $23,800
    On-market trade.
    01 Jul 2026 Ian Kadish Exercise 37,678 $75,732
    Conversion of securities. 740,241 rights
    01 Jul 2026 Ian Kadish Buy 37,678 $75,732
    Conversion of securities.
    24 Jun 2026 James Hall Transfer 225,271 $444,910
    Off-market transfer. Assuming off market transfer
    24 Jun 2026 James Hall Transfer 225,271 $444,910
    Off-market transfer. Assuming off market transfer
    24 Jun 2026 James Hall Buy 51,300 $100,701
    On-market trade.
    11 Jun 2026 James Hall Buy 12,000 $24,468
    On-market trade.
    02 Apr 2026 James Hall Issued 2,779 $6,615
    Dividend Reinvestment Plan (DRP).
    09 Mar 2026 James Hall Buy 10,000 $22,500
    On-market trade.
    06 Mar 2026 Laura McBain Buy 8,474 $19,913
    On-market trade.
    27 Feb 2026 Ingrid Player Buy 25,000 $60,402
    On-market trade.
    27 Feb 2026 Kevin (Kai-Chung) Shaw Buy 28,000 $68,040
    On-market trade.
    31 Dec 2025 James Hall Buy 6,200 $15,066
    On-market trade.
    22 Dec 2025 Ian Kadish Exercise 34,233 $82,843
    Conversion of securities. 7,77,919 rights
    22 Dec 2025 Ian Kadish Buy 34,233 $82,843
    Conversion of securities.
    16 Dec 2025 Ian Kadish Issued 235,596 $584,278
    Issue of securities. 812,132 Rights
    03 Oct 2025 James Hall Issued 2,652 $7,666
    Dividend Reinvestment Plan (DRP).

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Andrew James Fay Non-Executive Director Jul 2022
    Mr Fay brings to the Board over 35 years of experience in funds and investment management, including Chief Executive Officer and Chief Investment Officer roles at Deutsche Asset Management (Australia) Limited. He also held a few other senior investment roles at Deutsche Asset Management and previously at AMP Capital. From 1998 to 2006, he was a member of the Investment Board Committee of the Financial Services Council. Andrew is an experienced company director across ASX-listed, private and regulated entities and brings to the Board skills in finance and risk management, capital markets, executive remuneration frameworks, strategy, investment and corporate governance. Specifically, he has sector experience and expertise in financial services, including investment, funds, property and infrastructure management. External Roles: Chair of Growthpoint Properties Australia Chair of Utilities of Australia Pty Ltd Non-Executive Director of National Cardiac Pty Ltd.
    Ms Ingrid Anne Player Non-Executive Director Aug 2023
    Ms Player is an experienced former Executive and Non-Executive Director with international commercial and regulatory experience in mergers and acquisitions, corporate governance, capital developments, risk and sustainability that spans different markets and industries in Australia and Europe. Her experience includes her senior executive roles with leading healthcare providers, where she worked closely with the Board to deliver various capital raisings, retail listed notes, and debt finance deals. She was also instrumental in leading the integration of more than 50 businesses into the Group, implementing the first Reconciliation Action Plan and establishing diversity targets throughout the organization. Her roles included Group Executive for Legal, Governance and Sustainability as well as General Counsel and Company Secretary. She is the Chair of the Risk, Compliance and Sustainability Committee. External roles: Non-Executive Director of Cleanaway Waste Management Limited Non-Executive Director of Cogstate Limited Non-Executive Director of the Epworth Foundation.
    Mr James Tobias Hall Non-Executive DirectorNon-Executive Chairman Sep 2023
    Mr Hall has healthcare executive leadership experience in Australia and New Zealand and is an experienced Board and Committee Chair. From 2014 to 2022, Toby was the Group CEO of St Vincent Health Australia, the non-government provider of hospital and care services in the country. He has also overseen multi-site, for-profit-generating businesses at both board and executive levels in employment services, early learning services and aged care. Toby also has extensive involvement in policy development at a federal level in Australia, having served on committees established by Prime Ministers, Deputy Prime Ministers, Health Ministers, Employment and Social Services Ministers. External Roles: Serves as Non-Executive Director of Ingenia Communities Group and Director of Papua New Guinea Sustainable Development Fund and PT Siloam International Hospitals Tbk.
    Ms Laura Nicole McBain Non-Executive Director Dec 2024
    Ms McBain is an experienced Executive and Non-Executive Director with a background in the food, beverage, and consumer industries, specialising in brand development, fast growth, corporate governance, financial oversight, and business development. Her experience includes senior leadership roles as Managing Director at Bellamy's Australia Limited and Maggie Beer Holdings Limited, where she drove strategic growth, operational excellence, and stakeholder engagement. In recognition of her leadership and contributions, Laura was named the 2013 Telstra Tasmanian Businesswoman of the Year and the Telstra Australian Businesswoman of the Year (Private and Corporate). Previously, she was a Non-Executive Director of Lark Distilling Ltd and Export Finance Australia. She is the Member of the Risk, Compliance and Sustainability Committee.
    Dr Kevin (Kai-Chung) Shaw Non-Executive Director Dec 2024
    Mr Shaw is a qualified radiologist with sub-specialty training in neuroradiology and musculoskeletal imaging. He is the current Director of Medical Imaging at Barwon Health. He obtained his medical degree from Monash University in 2006 and completed his radiology training at Royal Melbourne Hospital. Kevin is also a Clinical Professor at Deakin Medical School. He is a past examiner for the Royal Australian and New Zealand College of Radiologists (RANZCR) and previously sat on the College Anatomy Exam Review Panel. He has been an MRI Clinical Reviewer for RANZCR since 2014. He is the Member of the Risk, Compliance and Sustainability Committee.
    Mr Manish Mittal Non-Executive Director Feb 2025
    Mr Mittal is professionally focused on MRI, including musculoskeletal, prostate and cardiac imaging in addition to extensive experience in neuroradiology and abdominal radiology. He also has experience in hospital settings including emergencies and trauma. Manish has worked within IDX and its precursor businesses for over 18 years and held senior clinical governance and leadership roles across a few IDX business units enabling the development of his deep understanding of the IDX operating businesses. He is the Member of the Risk, Compliance and Sustainability Committee.
    Mr Jason Martinez Chief Executive OfficerExecutive DirectorManaging Director Aug 2026
    Mr Martinez has 20 years' experience in the diagnostic imaging, health and medical sectors. Mr Martinez served as Executive General Manager for NSW, ACT and WA at I-MED Radiology.
    Mr John J Merity Company Secretary Jun 2024
    -
    Craig White CFO
    -
    John J Merity Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 85,886,682 23.02%
    J P Morgan Nominees Australia Pty Limited 68,044,538 18.24%
    Citicorp Nominees Pty Limited 64,008,263 17.16%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 10,502,876 2.82%
    BNP Paribas Noms Pty Ltd <Global Markets> 10,379,181 2.78%
    BNP Paribas Noms (Nz) Ltd 7,826,172 2.10%
    HSBC Custody Nominees (Australia) Limited A/C 2 6,224,275 1.67%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 5,874,991 1.57%
    HSBC Custody Nominees (Australia) Limited <NT Commwlth Super Corp A/c> 4,379,374 1.17%
    BNP Paribas Noms Pty Ltd 4,257,543 1.14%
    Kim New Holdings Pty Ltd 3,389,045 0.91%
    Lethean Holdings Pty Ltd <The Howitt No 8 A/c> 2,944,760 0.79%
    Idinoc Pty Ltd <J & R Conidi Family A/c> 2,502,713 0.67%
    Firbar Pty Ltd <The Howitt No 4 A/c> 2,357,230 0.63%
    First Samuel Ltd ACN 086243567 <ANF ITS MDA Clients A/c> 2,340,923 0.63%
    Masfen Securities Limited 2,250,000 0.60%
    Mittal Holdings Pty Ltd <Howitt No 12 A/c> 2,085,907 0.56%
    Citicorp Nominees Pty Limited <143212 NMMT Ltd A/C> 1,937,341 0.52%
    Wyndham Salter Pty Ltd <The Howitt No 10 A/c> 1,692,947 0.45%
    Warbont Nominees Pty Ltd <Settlement Entrepot A/c> 1,677,944 0.45%

    Profile

    since

    Note